Sign in
4

Changes in Ownership

Avalyn Pharma Inc. Filed Acc 0001193125-26-201887

10% owner bought 555,555 shares at $18.00 ($9,999,990)

  • 10% owner acquired 2,753,094 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
SR ONE CAPITAL MANAGEMENT, LLC 10% owner 2026-05-01 Conversion +1,419,298 1,419,298 I
SR ONE CAPITAL MANAGEMENT, LLC 10% owner 2026-05-01 Conversion +489,486 1,908,784 I
SR ONE CAPITAL MANAGEMENT, LLC 10% owner 2026-05-01 Purchase +277,778 $18.00 $5,000,004 2,186,562 I
SR ONE CAPITAL MANAGEMENT, LLC 10% owner 2026-05-01 Conversion +354,824 354,824 I
SR ONE CAPITAL MANAGEMENT, LLC 10% owner 2026-05-01 Conversion +489,486 844,310 I
SR ONE CAPITAL MANAGEMENT, LLC 10% owner 2026-05-01 Purchase +277,777 $18.00 $4,999,986 1,122,087 I
Derivatives
SR ONE CAPITAL MANAGEMENT, LLC 10% owner 2026-05-01 Conversion · Series C-1 Convertible Preferred Stock −27,309,719 0 I
SR ONE CAPITAL MANAGEMENT, LLC 10% owner 2026-05-01 Conversion · Series D Convertible Preferred Stock −9,418,561 0 I
SR ONE CAPITAL MANAGEMENT, LLC 10% owner 2026-05-01 Conversion · Series C-1 Convertible Preferred Stock −6,827,429 0 I
SR ONE CAPITAL MANAGEMENT, LLC 10% owner 2026-05-01 Conversion · Series D Convertible Preferred Stock −9,418,560 0 I
Open-market purchases · 555,555 sh · avg $18.00 · $9,999,990
Loading xslF345X06/ownership.xml…